BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15197170)

  • 1. Platelet-derived growth factor receptor transactivation mediates the trophic effects of angiotensin II in vivo.
    Kelly DJ; Cox AJ; Gow RM; Zhang Y; Kemp BE; Gilbert RE
    Hypertension; 2004 Aug; 44(2):195-202. PubMed ID: 15197170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.
    Perros F; Montani D; Dorfmüller P; Durand-Gasselin I; Tcherakian C; Le Pavec J; Mazmanian M; Fadel E; Mussot S; Mercier O; Hervé P; Emilie D; Eddahibi S; Simonneau G; Souza R; Humbert M
    Am J Respir Crit Care Med; 2008 Jul; 178(1):81-8. PubMed ID: 18420966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II stimulates phosphorylation of an ectodomain-truncated platelet-derived growth factor receptor-beta and its binding to class IA PI3K in vascular smooth muscle cells.
    Gao BB; Hansen H; Chen HC; Feener EP
    Biochem J; 2006 Jul; 397(2):337-44. PubMed ID: 16569213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.
    McGary EC; Onn A; Mills L; Heimberger A; Eton O; Thomas GW; Shtivelband M; Bar-Eli M
    J Invest Dermatol; 2004 Feb; 122(2):400-5. PubMed ID: 15009722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension.
    Jang SW; Ihm SH; Choo EH; Kim OR; Chang K; Park CS; Kim HY; Seung KB
    Hypertension; 2014 Jun; 63(6):1228-34. PubMed ID: 24591339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II modulates frizzled-2 receptor expression in rat vascular smooth muscle cells.
    Castoldi G; Redaelli S; van de Greef WM; di Gioia CR; Busca G; Sperti G; Stella A
    Clin Sci (Lond); 2005 Jun; 108(6):523-30. PubMed ID: 15667337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor.
    Abouantoun TJ; MacDonald TJ
    Mol Cancer Ther; 2009 May; 8(5):1137-47. PubMed ID: 19417143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
    Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M
    Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells.
    Li L; Blumenthal DK; Masaki T; Terry CM; Cheung AK
    J Cell Biochem; 2006 Dec; 99(6):1553-63. PubMed ID: 16817200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of transforming growth factor receptors by angiotensin II and transforming growth factor-beta1 in vascular smooth muscle.
    Siegert A; Ritz E; Orth S; Wagner J
    J Mol Med (Berl); 1999 May; 77(5):437-45. PubMed ID: 10426193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor.
    Bokemeyer D; Schmitz U; Kramer HJ
    Kidney Int; 2000 Aug; 58(2):549-58. PubMed ID: 10916078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells.
    Fukuda N; Hu WY; Kubo A; Kishioka H; Satoh C; Soma M; Izumi Y; Kanmatsuse K
    Am J Hypertens; 2000 Feb; 13(2):191-8. PubMed ID: 10701820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of Ang II on PDGF receptor expression in vascular smooth muscle cell].
    Sun YP; Xing DQ; Wang XT; Hu SY; Bai H; Wu LL
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 May; 21(2):166-9. PubMed ID: 21171332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells.
    Bouallegue A; Vardatsikos G; Srivastava AK
    Can J Physiol Pharmacol; 2009 Dec; 87(12):1009-18. PubMed ID: 20029537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II stimulates rat astrocyte mitogen-activated protein kinase activity and growth through EGF and PDGF receptor transactivation.
    Clark MA; Gonzalez N
    Regul Pept; 2007 Dec; 144(1-3):115-22. PubMed ID: 17688958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of profilin-1 in angiotensin II-induced vascular smooth muscle cell proliferation.
    Cheng JF; Ni GH; Chen MF; Li YJ; Wang YJ; Wang CL; Yuan Q; Shi RZ; Hu CP; Yang TL
    Vascul Pharmacol; 2011; 55(1-3):34-41. PubMed ID: 21586339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
    Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
    J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo activation of rat aortic platelet-derived growth factor and epidermal growth factor receptors by angiotensin II and hypertension.
    Kim S; Zhan Y; Izumi Y; Yasumoto H; Yano M; Iwao H
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2539-45. PubMed ID: 11116050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma.
    Katayama R; Huelsmeyer MK; Marr AK; Kurzman ID; Thamm DH; Vail DM
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):25-33. PubMed ID: 15108021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR.
    Tabet F; Schiffrin EL; Callera GE; He Y; Yao G; Ostman A; Kappert K; Tonks NK; Touyz RM
    Circ Res; 2008 Jul; 103(2):149-58. PubMed ID: 18566342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.